UK CMA launches probe into Thermo Fisher’s proposed acquisition of PPD
The CMA will assess if the PPD acquisition will reduce the competition within any market in the country.
deal
Baxter Set to Become a Strong Competitor in Connected Care with Hill-Rom Acquisition
The deal will make Baxter one of the leaders in the connected devices market and...
GE Healthcare to acquire surgical visualisation firm BK Medical for $1.45bn
The takeover will extend GE Healthcare’s ultrasound portfolio into surgical visualisation and boost growth in...
Smiths Group to sell medical division to ICU for $2.35bn
The deal will create a leading infusion therapy company with pro forma combined revenues of...
Abbott acquires Walk Vascular to bolster endovascular product portfolio
Abbott has gained rights to Walk Vascular’s JETi thrombectomy systems intended for intravascular clot removal.
Boston Scientific acquires surgical business of Lumenis for $1.07bn
BPEA will continue to hold the rights to Lumenis’ international aesthetics and ophthalmology businesses.
Illumina completes acquisition of multi-cancer test developer Grail
Grail will operate as a separate company until the European Commission's ongoing regulatory review completes.
Fulgent acquires CSI Laboratories to expand cancer testing expertise
Fulgent plans to develop a complete cancer testing solution by merging its NGS expertise with CSI’s diagnostics test menu.
Medtronic signs agreement to acquire Intersect ENT for $1.1bn
The deal will allow Medtronic to strengthen its portfolio of products for ear, nose and throat procedures.
InterVenn raises $201m to develop liquid biopsy assay
InterVenn will use the funds to grow the network of partners on its AI-powered glycoproteomics platform.
Misonix’s proposed merger with Bioventus faces investigation
Bioventus expects the Misonix merger to generate a pure-play regenerative medicine and orthopaedics company.
